Medicare Plans’ Administrative Expense in 2025

Medicare-focused health plans reduced per-member administrative costs by 0.3% in 2025, reversing 3.6% growth in 2024 and marking the slowest cost growth since 2015. Median administrative costs fell to $56.76 PMPM from $57.21, while account and membership administration costs rose only 0.5%, their slowest increase since 2021. The data point to modest administrative efficiency gains for Medicare plan operators.

Analysis

The sector-level cost deceleration is directionally supportive for Medicare Advantage (MA) operators, but the investable implication depends on whether savings are genuine operating leverage or merely lower enrollment/acquisition activity. For HUM, UNH, CVS and CNC, a 0.3% reduction on roughly $57 PMPM administrative expense is immaterial by itself; the more relevant read-through is that vendors, automation and scale may be finally offsetting wage inflation after several years of elevated service and compliance costs. Plans with fixed-cost absorption potential and stable membership—especially UNH and HUM—should retain more of any savings than subscale regional MA carriers.

The near-term market reaction should be limited because 2026 MA earnings remain dominated by medical-cost trend, CMS risk-adjustment/rate policy and Star Ratings rather than SG&A. Over the next 1-3 months, the key catalyst is third-quarter reporting: evidence of flat-to-down administrative PMPM alongside credible medical-cost guidance would support estimates and multiple expansion, while falling administrative cost paired with shrinking membership would be a negative signal. Investors should distinguish reported PMPM leverage from expense deferral; a rebound in call-center, utilization-management or compliance spending would invalidate the margin thesis.

Second-order beneficiaries include health-plan technology and services providers whose automation products can be sold as cost-control tools, but broad software read-through is weak without evidence that plans are increasing digital spend rather than simply cutting discretionary budgets. The contrarian view is that lower administrative cost is partially a lagging indicator of reduced growth investment, which can impair retention and Stars performance over 6-18 months. Thus this datapoint favors quality scale over a broad MA beta trade, particularly given persistent uncertainty around reimbursement and elevated utilization.

Key Decisions for Investors

• Maintain a selective long bias in UNH versus short CNC over a 3-6 month horizon: UNH has greater fixed-cost absorption and diversified earnings, while CNC remains more exposed to execution and membership volatility. Reassess if UNH reports administrative PMPM growth above medical-cost trend or if CNC demonstrates sustained membership growth with improving MLR.
• Add HUM only on evidence in the next earnings release that administrative PMPM is flat/down while 2026 margin targets and membership guidance are maintained; target a 10-15% upside re-rating from a credible earnings-reset confirmation, with downside defined by a medical-cost or Stars-guidance deterioration.
• Avoid treating the sector statistic as a standalone catalyst for CVS. Require confirmation that Aetna's cost improvement translates into segment margin rather than being offset by utilization pressure or incremental investment in MA retention; otherwise the more material drivers remain pharmacy-services economics and medical-cost development.
• Set an earnings-season watch item for MA administrative PMPM, membership growth and Star Ratings simultaneously. A pattern of lower administrative cost plus negative membership growth should be interpreted as expense retrenchment, not operating leverage, and would favor reducing MA exposure.